Yield10 Bioscience to Participate at the Benzinga Global Small Cap Conference on May 14, 2021
May 10, 2021 08:30 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced that management will participate at the Benzinga Global...
BioNTech Announces First Quarter 2021 Financial Results and Corporate Update
May 10, 2021 07:00 ET | BioNTech SE
More than 450 million doses of BNT162b2 supplied to 91 countries or territories worldwide as of May 6, 2021Signed agreements for over 1.8 billion doses of BNT162b2 in 2021 and first contracts signed...
BioNTech veröffentlicht Ergebnisse des ersten Quartals 2021 und Informationen zur Geschäftsentwicklung
May 10, 2021 07:00 ET | BioNTech SE
Auslieferung von weltweit mehr als 450 Millionen BNT162b2-Impfstoffdosen in 91 Länder oder Regionen bis zum 6. Mai 2021 erfolgtLiefervereinbarungen geschlossen für über 1,8 Milliarden...
Reed’s Inc. Announces Release Date of First Quarter 2021 Financial Results and Webcast
May 07, 2021 08:00 ET | Reeds, Inc.
NORWALK, Conn., May 07, 2021 (GLOBE NEWSWIRE) -- Reed’s Inc. (Nasdaq: REED), owner of the nation’s leading portfolio of handcrafted, all-natural beverages, today announced that it intends to issue...
BWEN Logo.png
Broadwind Announces First Quarter 2021 Results
May 07, 2021 07:00 ET | Broadwind
CICERO, Ill., May 07, 2021 (GLOBE NEWSWIRE) -- Broadwind (NASDAQ: BWEN), a diversified precision manufacturer of specialized components and solutions serving global markets, today announced results...
CV Sciences, Inc. to Announce First Quarter 2021 Results on May 13, 2021
May 06, 2021 07:00 ET | CV Sciences, Inc.
SAN DIEGO, May 06, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
Ansys Announces Financial Results With Record Q1 ACV, Revenue and Operating Cash Flow
May 05, 2021 16:30 ET | ANSYS, Inc.
Details related to our financial guidance, including assumptions and economic impacts of COVID-19, are detailed in our prepared remarks document. / Key Highlights - Q1 2021 GAAP revenue of $363.2...
Myriad Genetics CEO Paul J. Diaz to Present at Bank of America Securities 2021 Virtual Health Care Conference
May 05, 2021 16:05 ET | Myriad Genetics, Inc.
SALT LAKE CITY, May 05, 2021 (GLOBE NEWSWIRE) -- Paul J. Diaz, president and CEO of Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will discuss the...
Arbutus Biopharma Logo
Arbutus Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 05, 2021 07:30 ET | Arbutus Biopharma Corporation
AB-729, Arbutus’ proprietary subcutaneously delivered RNAi agent, continues to demonstrate robust and continuous declines in hepatitis B surface antigen (HBsAg) in subjects with chronic hepatitis B...
Optinose Reports First Quarter 2021 Financial Results and Operational Updates
May 05, 2021 07:00 ET | Optinose, Inc.
Company reports first quarter total revenue of $12.0 million First quarter 2021 XHANCE net revenue of $11.0 million increased 55% compared to first quarter 2020 Conference call and webcast to be...